SiliconANGLE
OpenAI acquires Orchestra Bio to bring AI agents into drug development
OpenAI acquires Orchestra Bio to bring AI agents into drug development - SiliconANGLE
Via SiliconANGLE
·Excerpt
UPDATED 19:40 EDT / OCTOBER 20 2026
AI
OpenAI acquires Orchestra Bio to bring AI agents into drug development
OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc.
Orchestra builds artificial intelligence agents that help pharmaceutical teams keep development programs on track,. Its staff and technology will now sit inside OpenAI’s Rosalind life sciences unit.
Much of OpenAI’s case for the deal comes down to how long drugs take to reach patients. Getting…
Courtesy
This story was originally published by SiliconANGLE. All rights belong to the original publisher.
Read the original on siliconangle.com ↗